Clinical Trial Sites: Key Contributors to Optimal Pediatric Drug Developments

When developing new medicines, pediatric considerations are no longer optional. Following the implementation of new pediatric regulations in the US, EU, UK and Switzerland, pediatric arms have become a integral part of drug development and are considered at an early stage of drug development.

The pharmaceutical industry’s growing commitment to pediatrics and the increased interest in therapeutics for rare diseases have heightened the demand for pediatric clinical trials as well as adult trials to include adolescents. For these trials to be successful, collaboration with sites and site networks is paramount. Join this session and become versed in the importance of the site’s involvement in pediatric study plans, protocol development, feasibility, recruitment optimization, and retention. Will also be discussed also the implication for sites of the inclusion of adolescents into adult trials.

Location: Virtual Experience Date: 21 April 2021 Time: 14:00 - 14:45 Martine Dehlinger-Kremer, PhD, MS